InvestorsHub Logo
Followers 10
Posts 653
Boards Moderated 0
Alias Born 05/18/2011

Re: Pharma Sleuth post# 389266

Wednesday, 10/18/2023 8:13:05 PM

Wednesday, October 18, 2023 8:13:05 PM

Post# of 401539
Hey PS, be careful here... not many people on this board (or in general) have common sense! J/K, J/K

"In order for you to be right, every drug pending would have to fail, and everyone would have to stop using Adderall".

Conversely, in order for Elite to be successful, just one of the top three products have to come to fruition. I'll lose my mind if all three are approved. Oh wait! Then there is the Prasco deal which STARTS in Jan, what do you all think that will do to Elite's top line revenue?

Immediate pipeline.......................................Status..............................IMS
1.) CNS Stimulant, Concerta...........................In development.................1.1 - 2.5 B
2.) Generic OxyContin.....................................FDA review........................720 M
3. ) CNS Stimulant, Vynanse...........................Studies complete...............5.3 B
4.) Anti metabolite............................................FDA review........................42 M
5.) Generic (Dopamine agonist) ER..................FDA review.......................12 M
6.) Jan 1, 2024 - Prasco to start selling Amphetamine ER (Generic Adderall XR) under Burel lable.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News